Literature DB >> 11744672

Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats.

Jiang-Yong Min1, Yinke Yang, Kimber L Converso, Lixin Liu, Qin Huang, James P Morgan, Yong-Fu Xiao.   

Abstract

Massive loss of cardiac myocytes after myocardial infarction (MI) is a common cause of heart failure. The present study was designed to investigate the improvement of cardiac function in MI rats after embryonic stem (ES) cell transplantation. MI in rats was induced by ligation of the left anterior descending coronary artery. Cultured ES cells used for cell transplantation were transfected with the marker green fluorescent protein (GFP). Animals in the treated group received intramyocardial injection of ES cells in injured myocardium. Compared with the MI control group injected with an equivalent volume of the cell-free medium, cardiac function in ES cell-implanted MI animals was significantly improved 6 wk after cell transplantation. The characteristic phenotype of engrafted ES cells was identified in implanted myocardium by strong positive staining to sarcomeric alpha-actin, cardiac alpha-myosin heavy chain, and troponin I. GFP-positive cells in myocardium sectioned from MI hearts confirmed the survival and differentiation of engrafted cells. In addition, single cells isolated from cell-transplanted MI hearts showed rod-shaped GFP-positive myocytes with typical striations. The present data demonstrate that ES cell transplantation is a feasible and novel approach to improve ventricular function in infarcted failing hearts.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11744672     DOI: 10.1152/jappl.2002.92.1.288

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  89 in total

Review 1.  Bone marrow cells and myocardial regeneration.

Authors:  Fu-Sheng Wang; Cathy Trester
Journal:  Int J Hematol       Date:  2004-05       Impact factor: 2.490

Review 2.  Stem cell therapy for ischemic heart disease.

Authors:  Mohammad Nurulqadr Jameel; Jianyi Zhang
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

Review 3.  Stem cells in the infarcted heart.

Authors:  Dinender K Singla
Journal:  J Cardiovasc Transl Res       Date:  2009-11-20       Impact factor: 4.132

Review 4.  In vivo imaging of embryonic stem cell therapy.

Authors:  Han Jiang; Zhen Cheng; Mei Tian; Hong Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-11-24       Impact factor: 9.236

Review 5.  Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.

Authors:  Jarmila Machackova; Judit Barta; Naranjan S Dhalla
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

Review 6.  Stem celltherapy for ischemic heart failure.

Authors:  Doreen Rosenstrauch; Gregor Poglajen; Nina Zidar; Igor D Gregoric
Journal:  Tex Heart Inst J       Date:  2005

7.  Factors Released from Embryonic Stem Cells Stimulate c-kit-FLK-1(+ve) Progenitor Cells and Enhance Neovascularization.

Authors:  Sumbul Fatma; Donald E Selby; Reetu D Singla; Dinender K Singla
Journal:  Antioxid Redox Signal       Date:  2010-07-28       Impact factor: 8.401

8.  Sequential development of hematopoietic and cardiac mesoderm during embryonic stem cell differentiation.

Authors:  Valerie Kouskoff; Georges Lacaud; Staci Schwantz; Hans Jöerg Fehling; Gordon Keller
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-02       Impact factor: 11.205

Review 9.  Cardiac repair by embryonic stem-derived cells.

Authors:  M Rubart; L J Field
Journal:  Handb Exp Pharmacol       Date:  2006

10.  Embryonic stem cells overexpressing Pitx2c engraft in infarcted myocardium and improve cardiac function.

Authors:  A K Guddati; José Javier Otero; Eric Kessler; Gary Aistrup; J Andrew Wasserstrom; Xiaoqiang Han; Jon W Lomasney; John A Kessler
Journal:  Int Heart J       Date:  2009-11       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.